← Open Payments lookup

SHELLEY SCHEKALL-CALDARERA: Open Payments

NPI 1871346619 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,270 in 109 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,125 · 2025 $2,270

Food & beverage: $2,160Education: $109
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.11$373
Neurocrine BioSciences, Inc.15$315
Otsuka America Pharmaceutical, Inc.13$303
ABBVIE INC.22$298
Teva Pharmaceuticals USA, Inc.5$287
Lundbeck LLC14$156
Corium, LLC10$138
Axsome Therapeutics, Inc.5$115
Bausch Health US, LLC3$69
Almatica Pharma LLC3$64

Products named: REXULTI, FANAPT, INGREZZA, VRAYLAR, AUSTEDO XR, Azstarys, Auvelity, APLENZIN.

Industry payments across KS — which companies pay providers there.